Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Hemorrhagic Shock
Interventions
DRUG

Red blood cells (0Rh D-neg)

Fresh produced RBC

DRUG

Whole blood (O Rh D-neg K-neg)

Fresh produced WB

DRUG

Freeze dried plasma (LyoPlas)

(LyoPlas N-w (German Red Cross)

Trial Locations (9)

2380

Innlandet Hospital Trust, Brumunddal

3004

Vestre Viken Hospital Trust, Drammen

4809

Sørlandet Hospital HF, Arendal

5021

Haukeland University Hospital, Bergen

6807

Helse Førde, Førde

7006

St Olav University Hospital, Trondheim

8100

Helse Stavanger HF, Stavanger

9038

University Hospital of North Norway, Tromsø

0450

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Sykehuset Innlandet HF

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

Sorlandet Hospital HF

OTHER_GOV

collaborator

St. Olavs Hospital

OTHER

collaborator

Helse Forde

OTHER

collaborator

Helse Stavanger HF

OTHER_GOV

collaborator

University Hospital of North Norway

OTHER

collaborator

Vestre Viken Hospital Trust

OTHER

lead

Haukeland University Hospital

OTHER

NCT02784951 - Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System | Biotech Hunter | Biotech Hunter